Alkermes (ALKS) Receivables - Net (2011 - 2026)
Alkermes (ALKS) reported Receivables - Net of $407.6 million for Q1 2026, up 27.9% year-over-year from $318.7 million in Q1 2025, and up 22.04% quarter-over-quarter from $334.0 million in Q4 2025.
Alkermes (ALKS) Receivables - Net (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has 16 years of Receivables - Net data on file, last reported at $407.6 million in Q1 2026.
- Receivables - Net for Q1 2026 came in at $407.6 million, up 27.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $407.6 million (up 27.9% YoY), and the FY2025 annual result was $334.0 million, down 13.13% from the prior year.
- Receivables - Net climbed to $407.6 million in Q1 2026 per ALKS's latest filing, from $334.0 million in the prior quarter.
- Over five years, Receivables - Net peaked at $407.6 million in Q1 2026 and troughed at $245.8 million in Q2 2022.
- A 5-year average of $324.6 million and a median of $334.0 million in 2025 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2022 and 2023: Receivables - Net fell 17.32% in 2022, then surged 36.06% in 2023.
- A 5-year view of Receivables - Net shows it stood at $288.0 million in 2022, then increased by 15.46% to $332.5 million in 2023, then climbed by 15.66% to $384.5 million in 2024, then dropped by 13.13% to $334.0 million in 2025, then gained by 22.04% to $407.6 million in 2026.
- Business Quant data shows ALKS's Receivables - Net at $407.6 million in Q1 2026, $334.0 million in Q4 2025, and $354.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 407.63 Mn |
| Mar 31, 2026 | 407.63 Mn |
| Dec 31, 2025 | 334.03 Mn |
| Dec 31, 2025 | 334.03 Mn |
| Sep 30, 2025 | 354.39 Mn |
| Sep 30, 2025 | 354.39 Mn |
| Jun 30, 2025 | 354.91 Mn |
| Jun 30, 2025 | 354.91 Mn |
| Mar 31, 2025 | 318.70 Mn |
| Mar 31, 2025 | 318.70 Mn |
| Dec 31, 2024 | 384.53 Mn |
| Dec 31, 2024 | 384.53 Mn |
| Sep 30, 2024 | 367.21 Mn |
| Sep 30, 2024 | 367.21 Mn |
| Jun 30, 2024 | 366.42 Mn |
| Jun 30, 2024 | 366.42 Mn |
| Mar 31, 2024 | 315.85 Mn |
| Mar 31, 2024 | 315.85 Mn |
| Dec 31, 2023 | 332.48 Mn |
| Dec 31, 2023 | 332.48 Mn |